Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment
<i>Ginkgo biloba</i> monotherapy was associated with preserved cognition, improved daily functioning, and reduced plasma Aβ oligomerization in amyloid PET-positive MCI patients. These findings suggest potential disease-modifying effects and warrant further validation in prospective, biomarker-based clinical trials.
Authors
- YoungSoon Yang (ORCID: https://orcid.org/0000-0002-2448-2599)
- Yong Tae Kwak (ORCID: https://orcid.org/0000-0003-4195-8971)
- Min‐Seong Koo
Institutions
- Soonchunhyang University (KR)
- Hyoja Geriatric Hospital (KR)
- Catholic Kwandong University International St. Mary's Hospital (KR)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.3389/fneur.2025.1639924
- Citations
- 5
- Primary Topic
- Ginkgo biloba and Cashew Applications
- Type
- article
- Field-Weighted Citation Impact
- 11.91
Funders
- Soonchunhyang University